The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat ...

Alex Inyatkin, the son of former UConn men's basketball player Ruslan Inyatkin, battles through autism, Tuberous sclerosis to ...

The recently published BEAM study revealed that Brivaracetam (BRV) sustained-release (SR) tablets are safe and effective for ...

The oversubscribed Series B will boost the clinical development of two RNAi therapies for epilepsy and Huntington’s disease ...

Alex Inyatkin, the son of former UConn men's basketball player Ruslan Inyatkin, battles through autism, Tuberous sclerosis to run track and sing in New York.

Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...

SAN FRANCISCO, CA / ACCESS Newswire / January 30, 2025 / A new study published in JAMA Network Open has found that while procedural prescription denials curb immediate drug costs, some denials result ...

Epilepsy causes recurrent, unprovoked seizures triggered by bursts of abnormal electrical activity in the brain.

Biotin is essential for hair and nail growth, and that simple fact is likely why it’s become such a buzz-worthy beauty ...

In the French director Catherine Breillat’s film “Fat Girl,” from 2001, two adolescent sisters go on summer holiday with ...

A study identifies the P2X7 receptor as a driver of post-traumatic epilepsy (PTE) following brain injuries. Blocking the receptor reduced brain hyperexcitability and damage in models.